Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The current status of Helicobacter pylori infection in Japan has not been investigated. We evaluated the status of H. pylori infection in a Japanese general population using large-scale resident-register-based sampling.

Methods

All 6069 adults in a rural town and 6000 adults in two urban cities (3000 each), selected by register-based random sampling, were enrolled in our health check-up program. Antibody titers against Helicobacter pylori (cut-off value was 3 U/mL by Eiken E-plate) were evaluated, and subjects with a positive result were encouraged to undergo further examinations.

Results

A total of 1586 subjects participated in serum sampling. The overall prevalence of H. pylori infection was 40.0% (634/1586), and it increased with age both in rural and urban areas. Although the overall positive rate was higher in the rural area (49.4%) than in the urban areas (35.6 and 32.3%), there was no difference in H. pylori status of younger subjects between the two areas. Among 634 patients with a positive titer, 374 (59.0%) underwent further examinations including endoscopic examination, and 180/634 (28.4%) patients received eradication therapy. Gastric neoplasms (three adenocarcinomas and one adenoma) were found in our screening program.

Conclusion

We clarified population-based random sampling data of H. pylori infection in a Japanese general population. In younger subjects, a decrease in the prevalence of H. pylori infection was confirmed both in rural and urban areas. This provides basic information for establishing a strategy to reduce gastric cancer deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cancer statistics. Cancer information service, national cancer center, Japan (vital statistics of Japan, ministry of health, labour and welfare)

  2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.

    Article  CAS  Google Scholar 

  3. Tsuda M, Asaka M, Kato M, et al. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Helicobacter. 2017;22:e12415.

    Article  Google Scholar 

  4. Kakiuchi T, Takamori A, Matsuo M. High prevalence of Helicobacter pylori infection in special needs schools in Japan. Front Pediatr. 2021;9: 697200.

    Article  Google Scholar 

  5. Haruma K, Suzuki T, Tsuda T, et al. Evaluation of tumor growth rate in patients with early gastric carcinoma of the elevated type. Gastrointest Radiol. 1991;16:289–92.

    Article  CAS  Google Scholar 

  6. Kowada A. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan. Epidemiol Infect. 2018;146:1834–40.

    Article  CAS  Google Scholar 

  7. Hamashima C, Shabana M, Okada K, et al. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci. 2015;106:1744–9.

    Article  CAS  Google Scholar 

  8. Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—“ABC method.” Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:405–14.

    Article  Google Scholar 

  9. Shimoyama T, Aoki M, Sasaki Y, et al. ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis. Gastric Cancer. 2012;15:331–4.

    Article  Google Scholar 

  10. Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20:3–7.

    Article  CAS  Google Scholar 

  11. Kotachi T, Ito M, Yoshihara M, et al. Serological evaluation of gastric cancer risk based on pepsinogen and Helicobacter pylori antibody: relationship to endoscopic findings. Digestion. 2017;95:314–8.

    Article  CAS  Google Scholar 

  12. Yamamoto C, Nagashima S, Isomura M, et al. Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers. Sci Rep. 2020;10:3857.

    Article  CAS  Google Scholar 

  13. Shuto M, Fujioka T, Matsunari O, et al. Association between gastric cancer risk and serum Helicobacter pylori antibody titers. Gastroenterol Res Pract. 2017;2017:1286198.

    Article  Google Scholar 

  14. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87–97.

    Article  Google Scholar 

  15. Nakajima S, Watanabe H, Shimbo T, et al. Incisura angularis belongs to fundic or transitional gland regions in Helicobacter pylori-naïve normal stomach: sub-analysis of the prospective multi-center study. Dig Endosc. 2021;33:125–32.

    Article  Google Scholar 

  16. Haruma K. Kyoto classification of gastritis. Nihon Medical Center. 2017

  17. Kato M, Ota H, Okuda M, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 revised edition. Helicobacter. 2019;24:e12597.

    Article  Google Scholar 

  18. https://www.pref.hiroshima.lg.jp/site/gan-net/yoboukenshin-jushinritsu-jushinritsu.html (in Japanese)

  19. Asaka M, Kobayashi M, Kudo T, et al. Gastric cancer deaths by age group in Japan: outlook on preventive measures for elderly adults. Cancer Sci. 2020;111:3845–53.

    Article  CAS  Google Scholar 

  20. Charvat H, Sasazuki S, Inoue M, et al. Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer. 2016;138:320–31.

    Article  CAS  Google Scholar 

  21. Fujisawa T, Kumagai T, Akamatsu T, et al. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol. 1999;94:2094–9.

    Article  CAS  Google Scholar 

  22. Shiotani A, Miyanishi T, Kamada T, et al. Helicobacter pylori infection and allergic diseases: epidemiological study in Japanese university students. J Gastroenterol Hepatol. 2008;23:e29-33.

    Article  Google Scholar 

  23. Wang C, Nishiyama T, Kikuchi S, et al. Changing trends in the prevalence of H. pylori infection in Japan (1908–2003): a systematic review and meta-regression analysis of 170,752 individuals. Sci Rep. 2017;2(7):15491.

    Article  Google Scholar 

  24. Ueda M, Kikuchi S, Kasugai T, et al. Helicobacter pylori risk associated with childhood home environment. Cancer Sci. 2003;94:914–8.

    Article  CAS  Google Scholar 

  25. https://www.pref.hiroshima.lg.jp/site/gan-net/yoboukenshin-jushinritsu-hakken.html (in Japanese)

  26. Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53:354–61.

    Article  Google Scholar 

  27. Boda T, Ito M, Yoshihara M, et al. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm. Helicobacter. 2014;19:1–8.

    Article  CAS  Google Scholar 

  28. http://www.jshr.jp/member (top page) (in Japanese)

Download references

Funding

This research was partly funded by a grant from the Japanese Ministry of Health, Labour, and Welfare (19HC1001), Viral Hepatitis Research Foundation of Japan and a scholarship grant from AbbVie Inc.

Author information

Authors and Affiliations

  1. Department of General Internal Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Masanori Ito

  2. Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Aya Sugiyama, Kanon Abe, Hirohito Imada, Serge Ouoba, Bunthen E, Ko Ko, Tomoyuki Akita & Junko Tanaka

  3. Hiroshima Prefectural Government Health and Welfare Division, Hiroshima, Japan

    Megumi Mino & Masaomi Kodama

  4. Department of Internal Medicine, Mazda Hospital, Hiroshima, Japan

    Yuko Nagaoki

  5. Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Science de La Santé (IRSS), Nanoro, Burkina Faso

    Serge Ouoba

  6. Payment Certification Agency, Ministry of Health, Phnom Penh, Cambodia

    Bunthen E

  7. General Affairs, Foundation for Community Health and Medicine Promotion in Hiroshima Prefecture, Hiroshima, Japan

    Takayuki Harakawa & Toru Sako

  8. Collaborative Research Laboratory of Medical Innovation, Hiroshima University, Hiroshima, Japan

    Kazuaki Chayama

Authors
  1. Masanori Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aya Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Megumi Mino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaomi Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuko Nagaoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kanon Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hirohito Imada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Serge Ouoba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bunthen E
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ko Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomoyuki Akita
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takayuki Harakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Toru Sako
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Kazuaki Chayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Junko Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MI and JT contributed to this work as corresponding authors. MI, KC, and JT designed the study. AS, MM, MK, YN, KA, HI, SO, BE, KK, TA, TH, TS, and JT participated in the acquisition of data. MI, AS, TA, and JT participated in the analysis and interpretation of the data. MI drafted the manuscript. AS, TA, and JT revised the manuscript. All authors approved the final version of the manuscript.

Corresponding authors

Correspondence to Masanori Ito or Junko Tanaka.

Ethics declarations

Conflict of interest

JT received a scholarship grant from AbbVie Inc.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, M., Sugiyama, A., Mino, M. et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. J Gastroenterol 57, 540–546 (2022). https://doi.org/10.1007/s00535-022-01885-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-022-01885-5

Keywords

Search

Navigation